Evidence map›Paper›PMID 35967591›Full record

ReviewJACC. Advances2022

Cardiovascular Complications of Pregnancy-Associated COVID-19 Infections.

Joan E Briller, Niti R Aggarwal, Melinda B Davis, Afshan B Hameed, Isabelle Malhamé, Zainab Mahmoud, Emily G McDonald, Glaucia Moraes de Oliveira, Odayme Quesada, Nandita S Scott and 2 more

Open access · diamondAbstract readReview
In one paragraph

Review in JACC. Advances, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
3.1field-weighted citation impact, top 7% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed, 19 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Review
  6. Article
  7. Review
  8. The role of the pregnancy heart team in clinical practice.Frontiers in cardiovascular medicine · 2023
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors at 10 institutions in 3 countries.

Joan E BrillerDivision of Cardiology, Department of Medicine and Department of Obstetrics and Gynecology, University of Illinois at Chicago, Chicago, Illinois, USA.
Niti R AggarwalDepartment of Cardiovascular Medicine, Mayo Clinic, Rochester, Minnesota, USA.
Melinda B DavisDivision of Cardiovascular Medicine, Department of Medicine, University of Michigan, Ann Arbor, Michigan, USA.
Afshan B HameedDepartment of Obstetrics and Gynecology and Division of Cardiology, Department of Medicine, University of California, Irvine Medical Center, Orange, California, USA.
Isabelle MalhaméDivision of General Internal Medicine, Department of Medicine, McGill University Health Centre, Montreal, Quebec, Canada.
Zainab MahmoudCardiovascular Division, Department of Medicine, Washington University School of Medicine, St Louis, Missouri, USA.
Emily G McDonaldDivision of General Internal Medicine, Department of Medicine, McGill University Health Centre, Montreal, Quebec, Canada.
Glaucia Moraes de OliveiraInternal Medicine Department, Univiersidade Federal do Rio de Janeiro, Rio de Janeiro, Brazil.
Odayme QuesadaWomen's Heart Center, The Christ Hospital Heart and Vascular Institute, Cincinnati, Ohio, USA.
Nandita S ScottDepartment of Medicine, Cardiology Division, Massachusetts General Hospital, Boston, Massachusetts, USA.
Jyoti SharmaDivision of Cardiology, Piedmont Heart Institute, Atlanta, Georgia, USA.
American College of Cardiology Cardiovascular Disease in Women Committee
McGill University Health Centre · CAChrist Hospital · USHarvard University · USMayo Clinic · USMichigan Medicine · USPiedmont Atlanta Hospital · USUniversidade Federal do Rio de Janeiro · BRUniversity of California, Irvine Medical Center · USUniversity of Illinois Chicago · USWashington University in St. Louis · US

Funding

Hypertensive Disorders of Pregnancy: Pathways to Future Cardiovascular DiseaseK23HL151867 · NHLBI · THE CHRIST HOSPITAL · PI QUESADA, ODAYME · 2020 to 2024
$799k
NHLBI NIH HHS K23 HL151867
6 · The paper itself

Abstract

Cardiovascular complications are frequently present in coronavirus-2019 (COVID-19) infection. These include microvascular and macrovascular thrombotic complications such as arterial and venous thromboembolism, myocardial injury or inflammation resulting in infarction, heart failure, and arrhythmias. Data suggest increased risk of adverse outcomes in pregnant compared with nonpregnant women of reproductive age with COVID-19 infection, including need for intensive care unit admission, mechanical ventilation, and extracorporeal membrane oxygenation utilization. Current statements addressing COVID-19-associated cardiac complications do not include pregnancy complications that may mimic COVID-19 complications such as peripartum cardiomyopathy, spontaneous coronary artery dissection, and preeclampsia. Unique to pregnancy, COVID-19 complications can result in preterm delivery and modify management of the pregnancy. Moreover, pregnancy has often been an exclusion criterion for enrollment in research studies. In this review, we summarize what is known about pregnancy-associated COVID-19 cardiovascular complications.

Indexed as

arrhythmiascardio-obstetricsCDC, Centers for Disease ControlCOVID-19, coronavirus-2019ECG, electrocardiogramECMO, extracorporeal membrane oxygenationLV, left ventricularMI, myocardial injuryPASC, postacute sequelae of SARS-CoV-2 infectionperipartum cardiomyopathyPPCM, peripartum cardiomyopathypreeclampsiaSCAD, spontaneous coronary artery dissectionthromboembolic diseaseTn, cardiac troponinvaccine induced thrombocytopenia

Identifiers

PMID35967591
PMCPMC9364954
OpenAlexW4293152550

What Socratic holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.